The FDA has warned about the risk of vision loss due to weight loss drugs
The use of weight loss medications may increase the likelihood of developing a rare optic nerve disease that can lead to complete loss of vision. This was announced on November 9 on the website of the US Food and Drug Administration (FDA).
"This is a rare disease that can lead to a sharp, painless decrease in visual acuity in one of the eyes, including complete loss of vision," the regulator said in a statement.
We are talking about non-arteritic anterior ischemic optic neuropathy, in which the blood supply to the optic nerve is disrupted. The disease can develop suddenly, without being accompanied by pain. If one eye is affected, the likelihood of similar disorders in the second also increases.
Due to the identified risks, the FDA has required manufacturers of the relevant medicines to supplement the information about the drugs with a warning about possible complications.
The agency recommended that patients seek immediate medical attention if they experience symptoms such as sudden blurred vision, blurred images, or changes in color perception. Doctors should also warn people in advance about the potential side effects of therapy. Among the circumstances that can increase the likelihood of developing the disease, the regulator identified diabetes mellitus, smoking, sleep breathing disorders, kidney pathology, high blood pressure and low hemoglobin levels. However, the exact mechanisms of the disease have not yet been definitively established.
The warning was based on the results of more than 100 clinical trials of GLP-1 RA group drugs. According to the data obtained, among those taking such medications, the incidence of the disease was 6.4 cases per 100,000 study participants. In the control group receiving placebo, the rate reached 3.8 cases per 100,000 people.
On August 11, Rospotrebnadzor began checking the sale of dietary supplements for weight loss after news about the content of sibutramine in them. The inspections were organized after an article by Izvestia about the sale of dietary supplements for weight loss containing the potent substance sibutramine, which can cause severe mental disorders, heart problems and even lead a person to intensive care.
Переведено сервисом «Яндекс Переводчик»